𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recurrent “Retinoic acid syndrome” during induction of remission in acute promyelocytic leukemia

✍ Scribed by Avichai Shimoni; Yaakov Maor-Kendler; Miron Prokocimer

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
195 KB
Volume
48
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemophagocytic syndrome associated with
Hemophagocytic syndrome associated with retinoic acid syndrome in acute promyelocytic leukemia
✍ J. García-Suárez; H. Bañas; I. Krsnik; D. De Miguel; E. Reyes; C. Burgaleta 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract A 56‐year‐old woman with an acute promyelocytic leukemia (APL) developed a severe __all‐trans__‐retinoic (ATRA) syndrome on day 17 of treatment. Shortly after, she presented a picture of pancytopenia, hepatosplenomegaly, increased triglycerides, ferritin, and liver enzymes. A bone marro

Rebound peripheral blastosis with subseq
Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia
✍ Robert Amato; Hagop Kantarjian; Ronald Walters; Michael Keating 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 1 views

A patient with acute promyelocytic leukemia manifested peripheral blastosis with 50% peripheral blasts and an absolute blast count of 10,0o0/pl 2 weeks after the start of induction chemotherapy. The subsequent disappearance of the peripheral and marrow blasts without further chemotherapy was noticed

ALL-TRANS RETINOIC ACID (ATRA) IN THE TR
ALL-TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)
✍ C. S. CHIM; Y. L. KWONG; R. LIANG; Y. C. CHU; C. H. CHAN; L. C. CHAN; K. F. WONG 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Acute promyelocytic leukemia is characterized by the reciprocal translocation of chromosomes 15 and 17. All-trans retinoic acid (ATRA) efficiently induces differentiation of the abnormal promyelocytes. In this study, we had used ATRA as the primary induction therapy for 17 newly diagnosed patients,